FDA approves first generic loteprednol eyedrop

• Posted on: Apr 23 2019
• By: Saratoga Opthalmology
• Leave a response

Akorn, Inc. announced the approval of their generic steroid eyedrop, loteprednol etabonate ophthalmic suspension 0.5%.
Source: AAO

Posted in: Uncategorized